Inflammatory myofibroblastic tumour of the bladder may express anaplastic lymphoma kinase by translocation‐dependent and translocation‐independent mechanisms: a report of two cases
暂无分享,去创建一个
P. Tan | E. Do | E. Koay | G. Yip | C. Kwan | L. Tan | S. Peh | S. Tan | Y-C Zhou | R. Ventura | B-K Poh | E. S. Koay
[1] T. Tsuzuki,et al. ALK-1 Expression in Inflammatory Myofibroblastic Tumor of the Urinary Bladder , 2004, The American journal of surgical pathology.
[2] E. Do,et al. Multi-Lineage Interrogation of the Performance Characteristics of a Split-Signal Fluorescence In Situ Hybridization Probe for Anaplastic Lymphoma Kinase Gene Rearrangements A Study of 101 Cases Characterized by Immunohistomorphology on Fixed Archival Tissue , 2004 .
[3] E. Jaffe. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .
[4] Ming Zhou,et al. Fusion of ALK to the Ran‐binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor , 2003, Genes, chromosomes & cancer.
[5] W. Sanger,et al. Expression of ALK1 and p80 in Inflammatory Myofibroblastic Tumor and Its Mesenchymal Mimics: A Study of 135 Cases , 2002, Modern Pathology.
[6] P. Marynen,et al. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large‐cell lymphoma and inflammatory myofibroblastic tumor , 2002, Genes, chromosomes & cancer.
[7] M. Ladanyi,et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. , 2001, The American journal of pathology.
[8] S. Perkins,et al. ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic Tumor , 2001, Modern Pathology.
[9] M. Werner,et al. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas , 2000, Leukemia.
[10] P. Chu,et al. Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases , 2000, Modern Pathology.
[11] P. D. Dal Cin,et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. , 2000, The American journal of pathology.
[12] P. Harnden,et al. Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications. , 1999, Histology and histopathology.
[13] J. Southgate,et al. Stromal and vascular invasion in an human in vitro bladder cancer model. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[14] K. Pulford,et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. , 1997, Blood.
[15] R. Moll,et al. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. , 1992, The American journal of pathology.
[16] R. Gascoyne,et al. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of six cases , 2003 .
[17] Np Wang. Coordinate expression of cytokeratin 7 and 20 defines unique subsets of carcinomas , 1995 .